Announced
Completed
MITOBRIDGE INC / ASTELLAS PHARMA INC. / Acquisition / Private / £335m
Synopsis
Tokyo, Japan-based Astellas Pharma Inc. acquired its partner Mitobridge, Inc., a biotechnology company focuses on mitochondrial therapeutics, for up to $450 million.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.